Market Overview

Buckingham Research Downgrades Teva Pharmaceutical Industries Limited to Neutral, Removes $56 P

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for TEVA

DateFirmActionFromTo
Jul 2015Morgan StanleyResumesOverweight
Jul 2015BMO CapitalUpgradesMarket PerformOutperform
Jul 2015Standpoint ResearchReiteratesBuy

View More Analyst Ratings for TEVA
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (TEVA)

Get Benzinga's Newsletters